title: Should Immune-Enhancing Formulations Be Used for Patients With Acute Respiratory Distress Syndrome?
abstract: The potential for regulating immune function in acute respiratory distress syndrome (ARDS) through enteral-administered anti-inflammatory lipids has generated much interest over the past 20 years. Yet recommendations remain inconclusive regarding the utilization of ω-3 fatty acids in patients with ARDS and acute lung injury (ALI). Studies are limited in number, with differing methods, small sample sizes, and conflicting results, making recommendations difficult to interpret.
authors.affiliation: Rush University Medical Center-Food and Nutrition, Chicago, Illinois, USA hannah_g_roosevelt@rush.edu.
authors.forename: Hannah
authors.initials: H
authors.lastname: Roosevelt
mesh_terms: D055371:Acute Lung Injury / Q000150:complications / Q000178:diet therapy / Q000276:immunology; D000893:Anti-Inflammatory Agents / Q000276:immunology / Q000627:therapeutic use*; D004750:Enteral Nutrition / Q000379:methods*; D015525:Fatty Acids, Omega-3 / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity / Q000187:drug effects / Q000276:immunology; D012128:Respiratory Distress Syndrome / Q000150:complications / Q000178:diet therapy* / Q000276:immunology*
chemical_list: D000893:Anti-Inflammatory Agents; D015525:Fatty Acids, Omega-3
keywords: acute respiratory distress syndrome; enteral nutrition; immune system; immunonutrition; nutritional support; omega-3 fatty acids